• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US SMARTSET GMV 40G US EO; BONE CEMENT : BONE CEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US SMARTSET GMV 40G US EO; BONE CEMENT : BONE CEMENT Back to Search Results
Model Number 5450-50-501
Device Problem Loss of or Failure to Bond (1068)
Patient Problems Adhesion(s) (1695); Cyst(s) (1800); Synovitis (2094)
Event Date 06/04/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.Dmf# 13704, trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form powder, strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Medical records received ad (b)(6) 2021 were reviewed.On (b)(6) 2014, the patient had a right total knee arthroplasty, single hamstring tendon lengthening, semimembranosus, for flexion contracture to address degenerative arthritis, varus deformity, and flexion contracture.Depuy components, including depuy patella and depuy cement x2 were used during this procedure.On (b)(6) 2019, the patient had a right revision, extensive for compartment synovectomy right knee, excision of cysts, and scar revision to address mechanical complication loosening , profound synovitis, massive cysts, debonding of the tibial tray from cement, and thickened scar tissue.Depuy components were used during this procedure, including competitor cement.During the procedure the surgeon observed cement debris.The patella was not revised.Doi: (b)(6) 2014 dor: (b)(6) 2019 (right knee).
 
Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot : a previous dhr review (b)(4) did not reveal any related manufacturing deviations or anomalies on the reported lot number (7786802).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMARTSET GMV 40G US EO
Type of Device
BONE CEMENT : BONE CEMENT
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key11641716
MDR Text Key244686257
Report Number1818910-2021-07538
Device Sequence Number1
Product Code MBB
UDI-Device Identifier10603295174295
UDI-Public10603295174295
Combination Product (y/n)Y
PMA/PMN Number
K081163
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup
Report Date 03/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/09/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2015
Device Model Number5450-50-501
Device Catalogue Number545050501
Device Lot Number7786802
Was Device Available for Evaluation? No
Date Manufacturer Received05/24/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATTUNE FB TIB BASE SZ 4 CEM; ATTUNE MEDIAL DOME PAT 35MM; ATTUNE PS FB INSRT SZ 5 6MM; ATTUNE PS FEM RT SZ 5 NAR CEM; SMARTSET GMV 40G US EO; SMARTSET MV 40G - EO; ATTUNE FB TIB BASE SZ 4 CEM; ATTUNE MEDIAL DOME PAT 35MM; ATTUNE PS FB INSRT SZ 5 6MM; ATTUNE PS FEM RT SZ 5 NAR CEM; SMARTSET GMV 40G US EO; SMARTSET MV 40G - EO
Patient Outcome(s) Required Intervention;
Patient Age60 YR
-
-